nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HRH1—atherosclerosis	0.407	1	CbGaD
Doxepin—CYP2C19—Rosuvastatin—atherosclerosis	0.023	0.0701	CbGbCtD
Doxepin—CYP2C19—Simvastatin—atherosclerosis	0.0214	0.0652	CbGbCtD
Doxepin—CYP2C19—Lovastatin—atherosclerosis	0.0209	0.0638	CbGbCtD
Doxepin—CYP2D6—Niacin—atherosclerosis	0.0206	0.0627	CbGbCtD
Doxepin—CYP2C9—Rosuvastatin—atherosclerosis	0.0191	0.0583	CbGbCtD
Doxepin—ABCB1—Ezetimibe—atherosclerosis	0.0185	0.0566	CbGbCtD
Doxepin—CYP2C9—Simvastatin—atherosclerosis	0.0178	0.0542	CbGbCtD
Doxepin—CYP2C9—Pravastatin—atherosclerosis	0.0174	0.053	CbGbCtD
Doxepin—CYP2C9—Lovastatin—atherosclerosis	0.0174	0.053	CbGbCtD
Doxepin—ABCB1—Simvastatin—atherosclerosis	0.0172	0.0526	CbGbCtD
Doxepin—ABCB1—Pravastatin—atherosclerosis	0.0169	0.0515	CbGbCtD
Doxepin—ABCB1—Lovastatin—atherosclerosis	0.0169	0.0515	CbGbCtD
Doxepin—CYP2D6—Simvastatin—atherosclerosis	0.0162	0.0496	CbGbCtD
Doxepin—CYP2D6—Pravastatin—atherosclerosis	0.0159	0.0485	CbGbCtD
Doxepin—CYP2D6—Lovastatin—atherosclerosis	0.0159	0.0485	CbGbCtD
Doxepin—CYP3A4—Ezetimibe—atherosclerosis	0.0111	0.0339	CbGbCtD
Doxepin—CYP3A4—Rosuvastatin—atherosclerosis	0.0111	0.0339	CbGbCtD
Doxepin—CYP3A4—Simvastatin—atherosclerosis	0.0103	0.0315	CbGbCtD
Doxepin—CYP3A4—Pravastatin—atherosclerosis	0.0101	0.0308	CbGbCtD
Doxepin—CYP3A4—Lovastatin—atherosclerosis	0.0101	0.0308	CbGbCtD
Doxepin—HTR2A—arteriole—atherosclerosis	0.000829	0.157	CbGeAlD
Doxepin—Pheniramine—HRH1—atherosclerosis	0.000559	0.0977	CrCbGaD
Doxepin—Clofedanol—HRH1—atherosclerosis	0.000509	0.089	CrCbGaD
Doxepin—HTR2A—vein—atherosclerosis	0.000494	0.0937	CbGeAlD
Doxepin—Doxylamine—HRH1—atherosclerosis	0.000465	0.0814	CrCbGaD
Doxepin—Tripelennamine—HRH1—atherosclerosis	0.000443	0.0774	CrCbGaD
Doxepin—Olopatadine—HRH1—atherosclerosis	0.000437	0.0765	CrCbGaD
Doxepin—Dimetindene—HRH1—atherosclerosis	0.000407	0.0711	CrCbGaD
Doxepin—Alimemazine—HRH1—atherosclerosis	0.000399	0.0698	CrCbGaD
Doxepin—Bromodiphenhydramine—HRH1—atherosclerosis	0.000364	0.0636	CrCbGaD
Doxepin—HTR2A—hindlimb—atherosclerosis	0.000328	0.0623	CbGeAlD
Doxepin—Tinnitus—Niacin—atherosclerosis	0.000306	0.00222	CcSEcCtD
Doxepin—Dysgeusia—Simvastatin—atherosclerosis	0.000305	0.00221	CcSEcCtD
Doxepin—Flushing—Niacin—atherosclerosis	0.000305	0.00221	CcSEcCtD
Doxepin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000303	0.0022	CcSEcCtD
Doxepin—Anaemia—Ezetimibe—atherosclerosis	0.000302	0.00219	CcSEcCtD
Doxepin—Tinnitus—Pravastatin—atherosclerosis	0.000302	0.00219	CcSEcCtD
Doxepin—Malaise—Lovastatin—atherosclerosis	0.0003	0.00218	CcSEcCtD
Doxepin—Cardiac disorder—Pravastatin—atherosclerosis	0.0003	0.00218	CcSEcCtD
Doxepin—Flushing—Pravastatin—atherosclerosis	0.0003	0.00218	CcSEcCtD
Doxepin—Muscle spasms—Simvastatin—atherosclerosis	0.000299	0.00217	CcSEcCtD
Doxepin—Vertigo—Lovastatin—atherosclerosis	0.000299	0.00217	CcSEcCtD
Doxepin—Angiopathy—Niacin—atherosclerosis	0.000298	0.00216	CcSEcCtD
Doxepin—Leukopenia—Lovastatin—atherosclerosis	0.000298	0.00216	CcSEcCtD
Doxepin—Chills—Niacin—atherosclerosis	0.000295	0.00214	CcSEcCtD
Doxepin—Malaise—Ezetimibe—atherosclerosis	0.000294	0.00214	CcSEcCtD
Doxepin—Vision blurred—Simvastatin—atherosclerosis	0.000293	0.00213	CcSEcCtD
Doxepin—Arrhythmia—Niacin—atherosclerosis	0.000293	0.00213	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000292	0.00212	CcSEcCtD
Doxepin—Tremor—Simvastatin—atherosclerosis	0.000292	0.00212	CcSEcCtD
Doxepin—Alopecia—Niacin—atherosclerosis	0.00029	0.00211	CcSEcCtD
Doxepin—Chills—Pravastatin—atherosclerosis	0.00029	0.0021	CcSEcCtD
Doxepin—Insomnia—Rosuvastatin—atherosclerosis	0.00029	0.0021	CcSEcCtD
Doxepin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000289	0.0021	CcSEcCtD
Doxepin—Arrhythmia—Pravastatin—atherosclerosis	0.000289	0.0021	CcSEcCtD
Doxepin—Palpitations—Ezetimibe—atherosclerosis	0.000289	0.00209	CcSEcCtD
Doxepin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000288	0.00209	CcSEcCtD
Doxepin—Anaemia—Simvastatin—atherosclerosis	0.000288	0.00209	CcSEcCtD
Doxepin—Erythema—Niacin—atherosclerosis	0.000286	0.00207	CcSEcCtD
Doxepin—Malnutrition—Niacin—atherosclerosis	0.000286	0.00207	CcSEcCtD
Doxepin—Alopecia—Pravastatin—atherosclerosis	0.000286	0.00207	CcSEcCtD
Doxepin—Cough—Ezetimibe—atherosclerosis	0.000285	0.00207	CcSEcCtD
Doxepin—Arthralgia—Lovastatin—atherosclerosis	0.000283	0.00206	CcSEcCtD
Doxepin—Chest pain—Lovastatin—atherosclerosis	0.000283	0.00206	CcSEcCtD
Doxepin—Myalgia—Lovastatin—atherosclerosis	0.000283	0.00206	CcSEcCtD
Doxepin—Anxiety—Lovastatin—atherosclerosis	0.000282	0.00205	CcSEcCtD
Doxepin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000282	0.00205	CcSEcCtD
Doxepin—Hypertension—Ezetimibe—atherosclerosis	0.000282	0.00204	CcSEcCtD
Doxepin—HTR2A—appendage—atherosclerosis	0.000282	0.0534	CbGeAlD
Doxepin—Flatulence—Niacin—atherosclerosis	0.000282	0.00204	CcSEcCtD
Doxepin—Malaise—Simvastatin—atherosclerosis	0.000281	0.00204	CcSEcCtD
Doxepin—Tension—Niacin—atherosclerosis	0.000281	0.00204	CcSEcCtD
Doxepin—Discomfort—Lovastatin—atherosclerosis	0.00028	0.00203	CcSEcCtD
Doxepin—Vertigo—Simvastatin—atherosclerosis	0.00028	0.00203	CcSEcCtD
Doxepin—Leukopenia—Simvastatin—atherosclerosis	0.000279	0.00202	CcSEcCtD
Doxepin—Chest pain—Ezetimibe—atherosclerosis	0.000278	0.00202	CcSEcCtD
Doxepin—Myalgia—Ezetimibe—atherosclerosis	0.000278	0.00202	CcSEcCtD
Doxepin—Arthralgia—Ezetimibe—atherosclerosis	0.000278	0.00202	CcSEcCtD
Doxepin—Nervousness—Niacin—atherosclerosis	0.000278	0.00201	CcSEcCtD
Doxepin—Flatulence—Pravastatin—atherosclerosis	0.000277	0.00201	CcSEcCtD
Doxepin—Dry mouth—Lovastatin—atherosclerosis	0.000277	0.00201	CcSEcCtD
Doxepin—Tension—Pravastatin—atherosclerosis	0.000276	0.002	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000276	0.002	CcSEcCtD
Doxepin—Dysgeusia—Pravastatin—atherosclerosis	0.000276	0.002	CcSEcCtD
Doxepin—Muscle spasms—Niacin—atherosclerosis	0.000275	0.00199	CcSEcCtD
Doxepin—Discomfort—Ezetimibe—atherosclerosis	0.000275	0.00199	CcSEcCtD
Doxepin—Pain—Rosuvastatin—atherosclerosis	0.000274	0.00199	CcSEcCtD
Doxepin—Constipation—Rosuvastatin—atherosclerosis	0.000274	0.00199	CcSEcCtD
Doxepin—Confusional state—Lovastatin—atherosclerosis	0.000274	0.00199	CcSEcCtD
Doxepin—Nervousness—Pravastatin—atherosclerosis	0.000273	0.00198	CcSEcCtD
Doxepin—Dry mouth—Ezetimibe—atherosclerosis	0.000272	0.00197	CcSEcCtD
Doxepin—Muscle spasms—Pravastatin—atherosclerosis	0.000271	0.00196	CcSEcCtD
Doxepin—Infection—Lovastatin—atherosclerosis	0.00027	0.00196	CcSEcCtD
Doxepin—Vision blurred—Niacin—atherosclerosis	0.000269	0.00195	CcSEcCtD
Doxepin—Confusional state—Ezetimibe—atherosclerosis	0.000269	0.00195	CcSEcCtD
Doxepin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000266	0.00193	CcSEcCtD
Doxepin—Vision blurred—Pravastatin—atherosclerosis	0.000265	0.00192	CcSEcCtD
Doxepin—Arthralgia—Simvastatin—atherosclerosis	0.000265	0.00192	CcSEcCtD
Doxepin—Chest pain—Simvastatin—atherosclerosis	0.000265	0.00192	CcSEcCtD
Doxepin—Myalgia—Simvastatin—atherosclerosis	0.000265	0.00192	CcSEcCtD
Doxepin—Infection—Ezetimibe—atherosclerosis	0.000265	0.00192	CcSEcCtD
Doxepin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000264	0.00192	CcSEcCtD
Doxepin—Anxiety—Simvastatin—atherosclerosis	0.000264	0.00192	CcSEcCtD
Doxepin—Tremor—Pravastatin—atherosclerosis	0.000264	0.00191	CcSEcCtD
Doxepin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000262	0.0019	CcSEcCtD
Doxepin—Discomfort—Simvastatin—atherosclerosis	0.000262	0.0019	CcSEcCtD
Doxepin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000261	0.0019	CcSEcCtD
Doxepin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000261	0.00189	CcSEcCtD
Doxepin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000261	0.00189	CcSEcCtD
Doxepin—Anaemia—Pravastatin—atherosclerosis	0.00026	0.00189	CcSEcCtD
Doxepin—Anorexia—Lovastatin—atherosclerosis	0.000259	0.00188	CcSEcCtD
Doxepin—Skin disorder—Ezetimibe—atherosclerosis	0.000259	0.00188	CcSEcCtD
Doxepin—Vertigo—Niacin—atherosclerosis	0.000257	0.00186	CcSEcCtD
Doxepin—Syncope—Niacin—atherosclerosis	0.000256	0.00186	CcSEcCtD
Doxepin—Confusional state—Simvastatin—atherosclerosis	0.000256	0.00186	CcSEcCtD
Doxepin—Leukopenia—Niacin—atherosclerosis	0.000256	0.00186	CcSEcCtD
Doxepin—Urticaria—Rosuvastatin—atherosclerosis	0.000255	0.00185	CcSEcCtD
Doxepin—Oedema—Simvastatin—atherosclerosis	0.000254	0.00184	CcSEcCtD
Doxepin—Malaise—Pravastatin—atherosclerosis	0.000254	0.00184	CcSEcCtD
Doxepin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000253	0.00184	CcSEcCtD
Doxepin—Vertigo—Pravastatin—atherosclerosis	0.000253	0.00183	CcSEcCtD
Doxepin—Palpitations—Niacin—atherosclerosis	0.000253	0.00183	CcSEcCtD
Doxepin—Infection—Simvastatin—atherosclerosis	0.000253	0.00183	CcSEcCtD
Doxepin—Leukopenia—Pravastatin—atherosclerosis	0.000252	0.00183	CcSEcCtD
Doxepin—Loss of consciousness—Niacin—atherosclerosis	0.000251	0.00182	CcSEcCtD
Doxepin—Cough—Niacin—atherosclerosis	0.00025	0.00181	CcSEcCtD
Doxepin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000249	0.0018	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000248	0.0018	CcSEcCtD
Doxepin—Insomnia—Lovastatin—atherosclerosis	0.000246	0.00178	CcSEcCtD
Doxepin—Cough—Pravastatin—atherosclerosis	0.000246	0.00178	CcSEcCtD
Doxepin—Thiothixene—HRH1—atherosclerosis	0.000244	0.0428	CrCbGaD
Doxepin—Paraesthesia—Lovastatin—atherosclerosis	0.000244	0.00177	CcSEcCtD
Doxepin—Myalgia—Niacin—atherosclerosis	0.000243	0.00177	CcSEcCtD
Doxepin—Arthralgia—Niacin—atherosclerosis	0.000243	0.00177	CcSEcCtD
Doxepin—Hypertension—Pravastatin—atherosclerosis	0.000243	0.00176	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000243	0.00176	CcSEcCtD
Doxepin—Anorexia—Simvastatin—atherosclerosis	0.000242	0.00176	CcSEcCtD
Doxepin—Dyspnoea—Lovastatin—atherosclerosis	0.000242	0.00176	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000242	0.00175	CcSEcCtD
Doxepin—Insomnia—Ezetimibe—atherosclerosis	0.000241	0.00175	CcSEcCtD
Doxepin—Myalgia—Pravastatin—atherosclerosis	0.00024	0.00174	CcSEcCtD
Doxepin—Chest pain—Pravastatin—atherosclerosis	0.00024	0.00174	CcSEcCtD
Doxepin—Arthralgia—Pravastatin—atherosclerosis	0.00024	0.00174	CcSEcCtD
Doxepin—Paraesthesia—Ezetimibe—atherosclerosis	0.000239	0.00174	CcSEcCtD
Doxepin—Dyspepsia—Lovastatin—atherosclerosis	0.000239	0.00173	CcSEcCtD
Doxepin—Anxiety—Pravastatin—atherosclerosis	0.000239	0.00173	CcSEcCtD
Doxepin—Dry mouth—Niacin—atherosclerosis	0.000238	0.00173	CcSEcCtD
Doxepin—Dyspnoea—Ezetimibe—atherosclerosis	0.000238	0.00172	CcSEcCtD
Doxepin—Discomfort—Pravastatin—atherosclerosis	0.000237	0.00172	CcSEcCtD
Doxepin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000236	0.00171	CcSEcCtD
Doxepin—Decreased appetite—Lovastatin—atherosclerosis	0.000236	0.00171	CcSEcCtD
Doxepin—Dyspepsia—Ezetimibe—atherosclerosis	0.000235	0.0017	CcSEcCtD
Doxepin—Fatigue—Lovastatin—atherosclerosis	0.000234	0.0017	CcSEcCtD
Doxepin—Oedema—Niacin—atherosclerosis	0.000233	0.00169	CcSEcCtD
Doxepin—Constipation—Lovastatin—atherosclerosis	0.000232	0.00169	CcSEcCtD
Doxepin—Pain—Lovastatin—atherosclerosis	0.000232	0.00169	CcSEcCtD
Doxepin—Confusional state—Pravastatin—atherosclerosis	0.000232	0.00168	CcSEcCtD
Doxepin—Decreased appetite—Ezetimibe—atherosclerosis	0.000232	0.00168	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000232	0.00168	CcSEcCtD
Doxepin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00023	0.00167	CcSEcCtD
Doxepin—Asthenia—Rosuvastatin—atherosclerosis	0.00023	0.00167	CcSEcCtD
Doxepin—Insomnia—Simvastatin—atherosclerosis	0.00023	0.00167	CcSEcCtD
Doxepin—Oedema—Pravastatin—atherosclerosis	0.00023	0.00167	CcSEcCtD
Doxepin—Fatigue—Ezetimibe—atherosclerosis	0.00023	0.00167	CcSEcCtD
Doxepin—Shock—Niacin—atherosclerosis	0.00023	0.00167	CcSEcCtD
Doxepin—Infection—Pravastatin—atherosclerosis	0.000228	0.00166	CcSEcCtD
Doxepin—Paraesthesia—Simvastatin—atherosclerosis	0.000228	0.00166	CcSEcCtD
Doxepin—Pain—Ezetimibe—atherosclerosis	0.000228	0.00165	CcSEcCtD
Doxepin—Constipation—Ezetimibe—atherosclerosis	0.000228	0.00165	CcSEcCtD
Doxepin—Tachycardia—Niacin—atherosclerosis	0.000228	0.00165	CcSEcCtD
Doxepin—Pruritus—Rosuvastatin—atherosclerosis	0.000227	0.00165	CcSEcCtD
Doxepin—Skin disorder—Niacin—atherosclerosis	0.000227	0.00164	CcSEcCtD
Doxepin—Dyspnoea—Simvastatin—atherosclerosis	0.000227	0.00164	CcSEcCtD
Doxepin—Hyperhidrosis—Niacin—atherosclerosis	0.000226	0.00164	CcSEcCtD
Doxepin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000225	0.00163	CcSEcCtD
Doxepin—Feeling abnormal—Lovastatin—atherosclerosis	0.000224	0.00162	CcSEcCtD
Doxepin—Dyspepsia—Simvastatin—atherosclerosis	0.000224	0.00162	CcSEcCtD
Doxepin—Anorexia—Niacin—atherosclerosis	0.000222	0.00161	CcSEcCtD
Doxepin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000222	0.00161	CcSEcCtD
Doxepin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000222	0.00161	CcSEcCtD
Doxepin—Decreased appetite—Simvastatin—atherosclerosis	0.000221	0.0016	CcSEcCtD
Doxepin—HRH2—cardiovascular system—atherosclerosis	0.000221	0.0418	CbGeAlD
Doxepin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00022	0.00159	CcSEcCtD
Doxepin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000219	0.00159	CcSEcCtD
Doxepin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000219	0.00159	CcSEcCtD
Doxepin—Fatigue—Simvastatin—atherosclerosis	0.000219	0.00159	CcSEcCtD
Doxepin—Anorexia—Pravastatin—atherosclerosis	0.000219	0.00159	CcSEcCtD
Doxepin—Hypotension—Niacin—atherosclerosis	0.000218	0.00158	CcSEcCtD
Doxepin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000218	0.00158	CcSEcCtD
Doxepin—Pain—Simvastatin—atherosclerosis	0.000217	0.00158	CcSEcCtD
Doxepin—Constipation—Simvastatin—atherosclerosis	0.000217	0.00158	CcSEcCtD
Doxepin—Urticaria—Lovastatin—atherosclerosis	0.000216	0.00157	CcSEcCtD
Doxepin—Body temperature increased—Lovastatin—atherosclerosis	0.000215	0.00156	CcSEcCtD
Doxepin—Abdominal pain—Lovastatin—atherosclerosis	0.000215	0.00156	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000213	0.00154	CcSEcCtD
Doxepin—Dizziness—Rosuvastatin—atherosclerosis	0.000212	0.00154	CcSEcCtD
Doxepin—Urticaria—Ezetimibe—atherosclerosis	0.000212	0.00154	CcSEcCtD
Doxepin—Insomnia—Niacin—atherosclerosis	0.000211	0.00153	CcSEcCtD
Doxepin—Body temperature increased—Ezetimibe—atherosclerosis	0.000211	0.00153	CcSEcCtD
Doxepin—Abdominal pain—Ezetimibe—atherosclerosis	0.000211	0.00153	CcSEcCtD
Doxepin—Paraesthesia—Niacin—atherosclerosis	0.00021	0.00152	CcSEcCtD
Doxepin—Feeling abnormal—Simvastatin—atherosclerosis	0.000209	0.00152	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000209	0.00152	CcSEcCtD
Doxepin—Dyspnoea—Niacin—atherosclerosis	0.000208	0.00151	CcSEcCtD
Doxepin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000208	0.00151	CcSEcCtD
Doxepin—Insomnia—Pravastatin—atherosclerosis	0.000208	0.00151	CcSEcCtD
Doxepin—Somnolence—Niacin—atherosclerosis	0.000207	0.0015	CcSEcCtD
Doxepin—Paraesthesia—Pravastatin—atherosclerosis	0.000206	0.0015	CcSEcCtD
Doxepin—Dyspepsia—Niacin—atherosclerosis	0.000205	0.00149	CcSEcCtD
Doxepin—Dyspnoea—Pravastatin—atherosclerosis	0.000205	0.00149	CcSEcCtD
Doxepin—Decreased appetite—Niacin—atherosclerosis	0.000203	0.00147	CcSEcCtD
Doxepin—Dyspepsia—Pravastatin—atherosclerosis	0.000202	0.00147	CcSEcCtD
Doxepin—Rash—Rosuvastatin—atherosclerosis	0.000202	0.00147	CcSEcCtD
Doxepin—Dermatitis—Rosuvastatin—atherosclerosis	0.000202	0.00146	CcSEcCtD
Doxepin—Urticaria—Simvastatin—atherosclerosis	0.000202	0.00146	CcSEcCtD
Doxepin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000201	0.00146	CcSEcCtD
Doxepin—HTR2A—artery—atherosclerosis	0.000201	0.0382	CbGeAlD
Doxepin—Abdominal pain—Simvastatin—atherosclerosis	0.000201	0.00146	CcSEcCtD
Doxepin—Body temperature increased—Simvastatin—atherosclerosis	0.000201	0.00146	CcSEcCtD
Doxepin—Headache—Rosuvastatin—atherosclerosis	0.000201	0.00146	CcSEcCtD
Doxepin—Hypersensitivity—Lovastatin—atherosclerosis	0.0002	0.00145	CcSEcCtD
Doxepin—Decreased appetite—Pravastatin—atherosclerosis	0.0002	0.00145	CcSEcCtD
Doxepin—Pain—Niacin—atherosclerosis	0.0002	0.00145	CcSEcCtD
Doxepin—Fatigue—Pravastatin—atherosclerosis	0.000198	0.00144	CcSEcCtD
Doxepin—Pain—Pravastatin—atherosclerosis	0.000196	0.00143	CcSEcCtD
Doxepin—Constipation—Pravastatin—atherosclerosis	0.000196	0.00143	CcSEcCtD
Doxepin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000196	0.00142	CcSEcCtD
Doxepin—Asthenia—Lovastatin—atherosclerosis	0.000195	0.00141	CcSEcCtD
Doxepin—Chlorprothixene—HRH1—atherosclerosis	0.000192	0.0337	CrCbGaD
Doxepin—Pruritus—Lovastatin—atherosclerosis	0.000192	0.00139	CcSEcCtD
Doxepin—Asthenia—Ezetimibe—atherosclerosis	0.000191	0.00139	CcSEcCtD
Doxepin—Gastrointestinal pain—Niacin—atherosclerosis	0.000191	0.00138	CcSEcCtD
Doxepin—Nausea—Rosuvastatin—atherosclerosis	0.00019	0.00138	CcSEcCtD
Doxepin—Feeling abnormal—Pravastatin—atherosclerosis	0.000189	0.00137	CcSEcCtD
Doxepin—Nortriptyline—HRH1—atherosclerosis	0.000189	0.033	CrCbGaD
Doxepin—Pruritus—Ezetimibe—atherosclerosis	0.000189	0.00137	CcSEcCtD
Doxepin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000188	0.00136	CcSEcCtD
Doxepin—Hypersensitivity—Simvastatin—atherosclerosis	0.000187	0.00136	CcSEcCtD
Doxepin—Diarrhoea—Lovastatin—atherosclerosis	0.000186	0.00135	CcSEcCtD
Doxepin—Urticaria—Niacin—atherosclerosis	0.000185	0.00134	CcSEcCtD
Doxepin—Abdominal pain—Niacin—atherosclerosis	0.000184	0.00134	CcSEcCtD
Doxepin—Body temperature increased—Niacin—atherosclerosis	0.000184	0.00134	CcSEcCtD
Doxepin—Urticaria—Pravastatin—atherosclerosis	0.000183	0.00132	CcSEcCtD
Doxepin—Asthenia—Simvastatin—atherosclerosis	0.000182	0.00132	CcSEcCtD
Doxepin—Diarrhoea—Ezetimibe—atherosclerosis	0.000182	0.00132	CcSEcCtD
Doxepin—Abdominal pain—Pravastatin—atherosclerosis	0.000182	0.00132	CcSEcCtD
Doxepin—Body temperature increased—Pravastatin—atherosclerosis	0.000182	0.00132	CcSEcCtD
Doxepin—Pruritus—Simvastatin—atherosclerosis	0.00018	0.0013	CcSEcCtD
Doxepin—Dizziness—Lovastatin—atherosclerosis	0.00018	0.0013	CcSEcCtD
Doxepin—Trimipramine—HRH1—atherosclerosis	0.000178	0.0311	CrCbGaD
Doxepin—Dizziness—Ezetimibe—atherosclerosis	0.000176	0.00128	CcSEcCtD
Doxepin—Diphenhydramine—HRH1—atherosclerosis	0.000175	0.0305	CrCbGaD
Doxepin—Diarrhoea—Simvastatin—atherosclerosis	0.000174	0.00126	CcSEcCtD
Doxepin—Vomiting—Lovastatin—atherosclerosis	0.000173	0.00125	CcSEcCtD
Doxepin—Hypersensitivity—Niacin—atherosclerosis	0.000172	0.00125	CcSEcCtD
Doxepin—Rash—Lovastatin—atherosclerosis	0.000171	0.00124	CcSEcCtD
Doxepin—Dermatitis—Lovastatin—atherosclerosis	0.000171	0.00124	CcSEcCtD
Doxepin—Promethazine—HRH1—atherosclerosis	0.000171	0.0299	CrCbGaD
Doxepin—Headache—Lovastatin—atherosclerosis	0.00017	0.00123	CcSEcCtD
Doxepin—HTR2A—endothelium—atherosclerosis	0.00017	0.0322	CbGeAlD
Doxepin—Vomiting—Ezetimibe—atherosclerosis	0.000169	0.00123	CcSEcCtD
Doxepin—Hypersensitivity—Pravastatin—atherosclerosis	0.000169	0.00123	CcSEcCtD
Doxepin—Dizziness—Simvastatin—atherosclerosis	0.000168	0.00122	CcSEcCtD
Doxepin—Rash—Ezetimibe—atherosclerosis	0.000168	0.00122	CcSEcCtD
Doxepin—Dermatitis—Ezetimibe—atherosclerosis	0.000168	0.00122	CcSEcCtD
Doxepin—Asthenia—Niacin—atherosclerosis	0.000167	0.00121	CcSEcCtD
Doxepin—Headache—Ezetimibe—atherosclerosis	0.000167	0.00121	CcSEcCtD
Doxepin—Pruritus—Niacin—atherosclerosis	0.000165	0.0012	CcSEcCtD
Doxepin—Orphenadrine—HRH1—atherosclerosis	0.000165	0.0289	CrCbGaD
Doxepin—Asthenia—Pravastatin—atherosclerosis	0.000165	0.0012	CcSEcCtD
Doxepin—Pruritus—Pravastatin—atherosclerosis	0.000163	0.00118	CcSEcCtD
Doxepin—Vomiting—Simvastatin—atherosclerosis	0.000162	0.00117	CcSEcCtD
Doxepin—Nausea—Lovastatin—atherosclerosis	0.000161	0.00117	CcSEcCtD
Doxepin—Rash—Simvastatin—atherosclerosis	0.00016	0.00116	CcSEcCtD
Doxepin—Dermatitis—Simvastatin—atherosclerosis	0.00016	0.00116	CcSEcCtD
Doxepin—Diarrhoea—Niacin—atherosclerosis	0.00016	0.00116	CcSEcCtD
Doxepin—Headache—Simvastatin—atherosclerosis	0.000159	0.00115	CcSEcCtD
Doxepin—Nausea—Ezetimibe—atherosclerosis	0.000158	0.00115	CcSEcCtD
Doxepin—Diarrhoea—Pravastatin—atherosclerosis	0.000157	0.00114	CcSEcCtD
Doxepin—HTR2A—blood vessel—atherosclerosis	0.000157	0.0297	CbGeAlD
Doxepin—Desipramine—HRH1—atherosclerosis	0.000155	0.0272	CrCbGaD
Doxepin—Dizziness—Niacin—atherosclerosis	0.000154	0.00112	CcSEcCtD
Doxepin—Dizziness—Pravastatin—atherosclerosis	0.000152	0.0011	CcSEcCtD
Doxepin—Nausea—Simvastatin—atherosclerosis	0.000151	0.00109	CcSEcCtD
Doxepin—Promazine—HRH1—atherosclerosis	0.000151	0.0263	CrCbGaD
Doxepin—Vomiting—Niacin—atherosclerosis	0.000148	0.00108	CcSEcCtD
Doxepin—Rash—Niacin—atherosclerosis	0.000147	0.00107	CcSEcCtD
Doxepin—Dermatitis—Niacin—atherosclerosis	0.000147	0.00107	CcSEcCtD
Doxepin—Headache—Niacin—atherosclerosis	0.000146	0.00106	CcSEcCtD
Doxepin—Vomiting—Pravastatin—atherosclerosis	0.000146	0.00106	CcSEcCtD
Doxepin—Rash—Pravastatin—atherosclerosis	0.000145	0.00105	CcSEcCtD
Doxepin—Dermatitis—Pravastatin—atherosclerosis	0.000145	0.00105	CcSEcCtD
Doxepin—CHRM2—cardiovascular system—atherosclerosis	0.000145	0.0274	CbGeAlD
Doxepin—Headache—Pravastatin—atherosclerosis	0.000144	0.00104	CcSEcCtD
Doxepin—Nausea—Niacin—atherosclerosis	0.000139	0.00101	CcSEcCtD
Doxepin—HRH2—liver—atherosclerosis	0.000136	0.0259	CbGeAlD
Doxepin—Nausea—Pravastatin—atherosclerosis	0.000136	0.00099	CcSEcCtD
Doxepin—Imipramine—HRH1—atherosclerosis	0.000132	0.0231	CrCbGaD
Doxepin—CHRM1—cardiovascular system—atherosclerosis	0.000132	0.025	CbGeAlD
Doxepin—HTR2B—cardiovascular system—atherosclerosis	0.000131	0.0248	CbGeAlD
Doxepin—Amitriptyline—HRH1—atherosclerosis	0.000131	0.0229	CrCbGaD
Doxepin—HTR1A—cardiovascular system—atherosclerosis	0.000117	0.0223	CbGeAlD
Doxepin—HTR2B—adipose tissue—atherosclerosis	0.000116	0.0219	CbGeAlD
Doxepin—ADRA1A—cardiovascular system—atherosclerosis	0.000108	0.0205	CbGeAlD
Doxepin—KCNH2—cardiovascular system—atherosclerosis	0.000105	0.0198	CbGeAlD
Doxepin—CHRM3—adipose tissue—atherosclerosis	0.000104	0.0197	CbGeAlD
Doxepin—ABCB1—blood vessel—atherosclerosis	0.000103	0.0195	CbGeAlD
Doxepin—HRH1—connective tissue—atherosclerosis	9.63e-05	0.0182	CbGeAlD
Doxepin—ORM1—liver—atherosclerosis	9.6e-05	0.0182	CbGeAlD
Doxepin—ADRA1A—adipose tissue—atherosclerosis	9.54e-05	0.0181	CbGeAlD
Doxepin—ADRA2A—connective tissue—atherosclerosis	9.46e-05	0.0179	CbGeAlD
Doxepin—ADRA2C—adipose tissue—atherosclerosis	9.1e-05	0.0172	CbGeAlD
Doxepin—CYP2C9—cardiovascular system—atherosclerosis	8.5e-05	0.0161	CbGeAlD
Doxepin—HTR2A—connective tissue—atherosclerosis	8.04e-05	0.0152	CbGeAlD
Doxepin—Oxcarbazepine—ALB—atherosclerosis	7.77e-05	0.0136	CrCbGaD
Doxepin—HRH1—adipose tissue—atherosclerosis	7.39e-05	0.014	CbGeAlD
Doxepin—ADRA2A—adipose tissue—atherosclerosis	7.26e-05	0.0138	CbGeAlD
Doxepin—HTR2A—cardiovascular system—atherosclerosis	7e-05	0.0133	CbGeAlD
Doxepin—CYP2C19—liver—atherosclerosis	6.78e-05	0.0128	CbGeAlD
Doxepin—ADRA1A—liver—atherosclerosis	6.69e-05	0.0127	CbGeAlD
Doxepin—ADRA2C—liver—atherosclerosis	6.38e-05	0.0121	CbGeAlD
Doxepin—Thiothixene—ALB—atherosclerosis	5.64e-05	0.00987	CrCbGaD
Doxepin—CYP1A2—liver—atherosclerosis	5.53e-05	0.0105	CbGeAlD
Doxepin—CYP2C9—liver—atherosclerosis	5.25e-05	0.00996	CbGeAlD
Doxepin—ABCB1—cardiovascular system—atherosclerosis	4.59e-05	0.00869	CbGeAlD
Doxepin—Clomipramine—ALB—atherosclerosis	4.46e-05	0.0078	CrCbGaD
Doxepin—Nortriptyline—ALB—atherosclerosis	4.36e-05	0.00763	CrCbGaD
Doxepin—HTR2A—liver—atherosclerosis	4.33e-05	0.0082	CbGeAlD
Doxepin—ABCB1—adipose tissue—atherosclerosis	4.04e-05	0.00766	CbGeAlD
Doxepin—CYP3A4—liver—atherosclerosis	4.01e-05	0.00759	CbGeAlD
Doxepin—CYP2D6—liver—atherosclerosis	3.94e-05	0.00747	CbGeAlD
Doxepin—Amitriptyline—ALB—atherosclerosis	3.03e-05	0.00529	CrCbGaD
Doxepin—ABCB1—liver—atherosclerosis	2.84e-05	0.00537	CbGeAlD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	2.62e-06	2.24e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AGT—atherosclerosis	2.61e-06	2.24e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	2.61e-06	2.24e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—LPL—atherosclerosis	2.61e-06	2.23e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.6e-06	2.23e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	2.59e-06	2.22e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	2.58e-06	2.21e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—atherosclerosis	2.58e-06	2.21e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	2.58e-06	2.21e-05	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.58e-06	2.21e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	2.57e-06	2.2e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.56e-06	2.2e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—atherosclerosis	2.56e-06	2.19e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CAV1—atherosclerosis	2.56e-06	2.19e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—atherosclerosis	2.56e-06	2.19e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	2.55e-06	2.19e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOA1—atherosclerosis	2.55e-06	2.19e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	2.55e-06	2.18e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—atherosclerosis	2.54e-06	2.18e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	2.54e-06	2.18e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.53e-06	2.17e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CAV1—atherosclerosis	2.53e-06	2.17e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.53e-06	2.17e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.53e-06	2.17e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOA1—atherosclerosis	2.53e-06	2.17e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.52e-06	2.16e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.51e-06	2.15e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.49e-06	2.14e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.48e-06	2.13e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CD36—atherosclerosis	2.48e-06	2.12e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.47e-06	2.12e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	2.47e-06	2.11e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.46e-06	2.11e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.46e-06	2.11e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.46e-06	2.1e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.45e-06	2.1e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.45e-06	2.1e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—atherosclerosis	2.44e-06	2.09e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2.44e-06	2.09e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2.42e-06	2.08e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2.42e-06	2.07e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.41e-06	2.07e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	2.41e-06	2.07e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.41e-06	2.06e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	2.4e-06	2.05e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—atherosclerosis	2.4e-06	2.05e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	2.39e-06	2.05e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	2.39e-06	2.04e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—atherosclerosis	2.38e-06	2.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	2.38e-06	2.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	2.38e-06	2.04e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.37e-06	2.03e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.37e-06	2.03e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	2.37e-06	2.03e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	2.36e-06	2.02e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.35e-06	2.01e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	2.34e-06	2.01e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—atherosclerosis	2.34e-06	2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	2.34e-06	2e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.34e-06	2e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	2.34e-06	2e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	2.33e-06	2e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.33e-06	2e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.33e-06	1.99e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	2.32e-06	1.99e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	2.32e-06	1.98e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.31e-06	1.98e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARA—atherosclerosis	2.3e-06	1.97e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—atherosclerosis	2.3e-06	1.97e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—atherosclerosis	2.29e-06	1.97e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2.29e-06	1.97e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	2.29e-06	1.96e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—atherosclerosis	2.29e-06	1.96e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—atherosclerosis	2.28e-06	1.95e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.27e-06	1.95e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	2.26e-06	1.94e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—atherosclerosis	2.26e-06	1.93e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	2.25e-06	1.93e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.25e-06	1.93e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—atherosclerosis	2.25e-06	1.93e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—atherosclerosis	2.24e-06	1.92e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—atherosclerosis	2.23e-06	1.91e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	2.23e-06	1.91e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—atherosclerosis	2.23e-06	1.91e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.22e-06	1.9e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—atherosclerosis	2.2e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.2e-06	1.89e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	2.2e-06	1.89e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	2.2e-06	1.88e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.2e-06	1.88e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—atherosclerosis	2.2e-06	1.88e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—atherosclerosis	2.19e-06	1.87e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—atherosclerosis	2.19e-06	1.87e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—atherosclerosis	2.19e-06	1.87e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.18e-06	1.87e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	2.18e-06	1.87e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—atherosclerosis	2.18e-06	1.86e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—atherosclerosis	2.17e-06	1.86e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAV1—atherosclerosis	2.17e-06	1.86e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	2.17e-06	1.86e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.16e-06	1.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.16e-06	1.85e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	2.16e-06	1.85e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOA1—atherosclerosis	2.16e-06	1.85e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.16e-06	1.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.16e-06	1.85e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	2.15e-06	1.84e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.15e-06	1.84e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.15e-06	1.84e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	2.15e-06	1.84e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—atherosclerosis	2.14e-06	1.84e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	2.14e-06	1.84e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	2.14e-06	1.84e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	2.14e-06	1.83e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.13e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.13e-06	1.82e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.12e-06	1.82e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—atherosclerosis	2.12e-06	1.82e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.12e-06	1.82e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.12e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	2.12e-06	1.82e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.12e-06	1.81e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	2.12e-06	1.81e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	2.11e-06	1.81e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	2.11e-06	1.81e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOB—atherosclerosis	2.11e-06	1.81e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	2.1e-06	1.8e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—atherosclerosis	2.1e-06	1.8e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.09e-06	1.79e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.09e-06	1.79e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.09e-06	1.79e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.08e-06	1.78e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	2.08e-06	1.78e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	2.08e-06	1.78e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	2.08e-06	1.78e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	2.08e-06	1.78e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—atherosclerosis	2.05e-06	1.76e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.05e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.05e-06	1.75e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—atherosclerosis	2.02e-06	1.73e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	2.02e-06	1.73e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—atherosclerosis	2.01e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—atherosclerosis	2e-06	1.72e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—atherosclerosis	2e-06	1.72e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2e-06	1.71e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.99e-06	1.7e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.99e-06	1.7e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.98e-06	1.69e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.97e-06	1.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.97e-06	1.69e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.96e-06	1.68e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—atherosclerosis	1.96e-06	1.68e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.96e-06	1.68e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—atherosclerosis	1.96e-06	1.68e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.95e-06	1.67e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.95e-06	1.67e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.94e-06	1.67e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.94e-06	1.66e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—atherosclerosis	1.94e-06	1.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.94e-06	1.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.93e-06	1.66e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—atherosclerosis	1.93e-06	1.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.93e-06	1.65e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.93e-06	1.65e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.93e-06	1.65e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.92e-06	1.65e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.92e-06	1.65e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.92e-06	1.64e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—atherosclerosis	1.92e-06	1.64e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—atherosclerosis	1.91e-06	1.64e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.91e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.9e-06	1.63e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—atherosclerosis	1.9e-06	1.63e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.89e-06	1.62e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—atherosclerosis	1.88e-06	1.61e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—atherosclerosis	1.87e-06	1.6e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.86e-06	1.59e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.85e-06	1.59e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.85e-06	1.58e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.85e-06	1.58e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.84e-06	1.58e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.83e-06	1.57e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.82e-06	1.56e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.82e-06	1.56e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.81e-06	1.55e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.8e-06	1.55e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.8e-06	1.54e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.8e-06	1.54e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.79e-06	1.54e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—atherosclerosis	1.79e-06	1.53e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.79e-06	1.53e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.79e-06	1.53e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARA—atherosclerosis	1.78e-06	1.52e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.77e-06	1.52e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.77e-06	1.52e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.77e-06	1.52e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.77e-06	1.51e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.77e-06	1.51e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.75e-06	1.5e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—atherosclerosis	1.72e-06	1.48e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—atherosclerosis	1.71e-06	1.47e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.69e-06	1.45e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—atherosclerosis	1.69e-06	1.45e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—atherosclerosis	1.68e-06	1.44e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—atherosclerosis	1.67e-06	1.43e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—atherosclerosis	1.67e-06	1.43e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.66e-06	1.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.64e-06	1.41e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—atherosclerosis	1.64e-06	1.4e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.63e-06	1.4e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.57e-06	1.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.56e-06	1.34e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.52e-06	1.3e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.52e-06	1.3e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.5e-06	1.29e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.5e-06	1.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.5e-06	1.28e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—atherosclerosis	1.49e-06	1.27e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—atherosclerosis	1.47e-06	1.26e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.45e-06	1.24e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.44e-06	1.24e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—atherosclerosis	1.44e-06	1.23e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.4e-06	1.2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.38e-06	1.18e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—atherosclerosis	1.38e-06	1.18e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—atherosclerosis	1.36e-06	1.17e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.36e-06	1.16e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—atherosclerosis	1.36e-06	1.16e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.35e-06	1.16e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.35e-06	1.15e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.33e-06	1.14e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.33e-06	1.14e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—atherosclerosis	1.32e-06	1.13e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.27e-06	1.09e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—atherosclerosis	1.26e-06	1.08e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.25e-06	1.07e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.25e-06	1.07e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.25e-06	1.07e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.24e-06	1.06e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.24e-06	1.06e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.23e-06	1.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.23e-06	1.05e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.16e-06	9.9e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.14e-06	9.77e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—atherosclerosis	9.66e-07	8.28e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—atherosclerosis	9.43e-07	8.08e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—atherosclerosis	8.89e-07	7.61e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—atherosclerosis	8.81e-07	7.55e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—atherosclerosis	7.53e-07	6.45e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—atherosclerosis	5.81e-07	4.98e-06	CbGpPWpGaD
